PRF Technologies (PRFX) Cash from Financing Activities (2020 - 2023)

PRF Technologies (PRFX) posted quarterly Cash from Financing Activities of $1.0 million for Q4 2023, down 71.56% on a QoQ basis from $3.6 million in Q3 2023.

PRF Technologies (PRFX) Cash from Financing Activities (2020 - 2023) Analysis & Trends

PRF Technologies (PRFX) has reported Cash from Financing Activities for 3 consecutive years, with $1.0 million the latest figure, recorded in Q4 2023.

  • Quarterly Cash from Financing Activities changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $6.5 million (changed N/A YoY) and the FY2025 annual result came in at $3.8 million, down 56.92% from the prior year.
  • Cash from Financing Activities retreated to $1.0 million in Q4 2023 per PRFX's latest filing, from $3.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PRFX reached as high as $7.5 billion in Q3 2021 and fell as low as -$7.5 billion in Q4 2021.
  • A 3-year average of $4.9 million and a median of $4.6 million in 2021 frame the typical range for Cash from Financing Activities.
  • The largest YoY upside for Cash from Financing Activities was 42899.34% in 2021 against a maximum downside of 42899.34% in 2021.
  • Year by year, Cash from Financing Activities stood at $17.4 million in 2020, then sank by 43088.25% to -$7.5 billion in 2021, then soared by 100.01% to $1.0 million in 2023.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.0 million, $3.6 million, and -$7.5 billion for Q4 2023, Q3 2023, and Q4 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 PRF Technologies 745,168.93 451,168.93 - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.02 Mn
Dec 31, 2023 1.02 Mn
Sep 30, 2023 3.59 Mn
Sep 30, 2023 3.59 Mn
Dec 31, 2021 -7.48 Bn
Dec 31, 2021 -7.48 Bn
Sep 30, 2021 7.48 Bn
Sep 30, 2021 7.48 Bn
Mar 31, 2021 5.55 Mn
Mar 31, 2021 5.55 Mn
Sep 30, 2020 17.39 Mn
Sep 30, 2020 17.39 Mn